-
Consensus Rating
HoldBased on 28 Analyst Ratings
-
Consensus Price Target
$5.0027.23% Upside
Exagen Inc. Frequently Asked Questions
-
What analysts cover Exagen Inc.?
Exagen Inc. has been rated by research analysts at BTIG, Canaccord Genuity in the past 90 days.